Status:
NOT_YET_RECRUITING
Bioptron Light Therapy for Dysmenorrhea in Obese Adolesences: RCT
Lead Sponsor:
Alaa Noureldeen Kora
Conditions:
Dysmenorrhea Primary
Obesity and Overweight
Eligibility:
FEMALE
16-18 years
Phase:
NA
Brief Summary
Dysmenorrhea is the most common health problem in women in the reproductive age(Bakhsh et al., 2022). The primary dysmenorrhea starts shortly after the menarche the pain lasting 1 to 3 days that start...
Eligibility Criteria
Inclusion
- 144 female adolescences suffering from primary dysmenorrhea pain determined according to the sample size calculation adapted from (Gu et al., 2022).
- They will be selected from the outpatient's clinic of the faculty of Physical Therapy Sinai University.
- Their chronological age ranged from 16 to 18 years old.
Exclusion
- Those who were taking anti-psychotic or anti-depressant medications, patients with any skin lesion or infection.
- Gynecological disorders included cervical cancer, ovarian tumors, endometriosis, uterine fibroids, polycystic ovarian syndrome, and other conditions that can affect menstruation.
Key Trial Info
Start Date :
August 1 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 31 2025
Estimated Enrollment :
144 Patients enrolled
Trial Details
Trial ID
NCT06992349
Start Date
August 1 2025
End Date
August 31 2025
Last Update
May 28 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sinai University
Ismailia, Egypt, 11749